Long-term results of the Spanish trial on treatment and survival of patients with predominantly mild heart failure

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 5, 1999, Pages 733-740

  Cosin Aguilar J ^a   Marrugat, J ^b   Sanz, G ^c   Masso J ^d   Gil, M ^b   Vargas, R ^e   Perez Casar F ^f   Simarro, E ^g   De Armas, D ^h   Garcia Garcia J ⁱ   Azpitarte, J ^j   Diago, J L ^k   Rodrigo Trallero, G ^l   Lekuona, I ^m   Domingo, E ⁿ   Marin Huerta, E ^o  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d Laboratoris Dr Esteve SA   (Spain)

^e Hospital El Sabinal   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g HOSPITAL DE LEÓN   (Spain)

^h HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^k HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^l HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^m HOSPITAL DE GALDAKAO   (Spain)

ⁿ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^o HOSPITAL RAMÓN Y CAJAL   (Spain)

more..

Author keywords

ACE inhibitors; Captopril; Digoxin; Heart failure; Survival; Trials

Indexed keywords

CAPTOPRIL; DIGOXIN; DIURETIC AGENT;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG BLOOD LEVEL; DRUG EFFICACY; ECHOCARDIOGRAPHY; EYE TOXICITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HOLTER MONITORING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; SURVIVAL; VERTIGO;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; CARDIAC OUTPUT, LOW; CARDIOTONIC AGENTS; DIGOXIN; DIURETICS; DRUG THERAPY, COMBINATION; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SPAIN; SURVIVAL ANALYSIS;

EID: 0032941918     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199905000-00009     Document Type: Article

References (33)

1. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;121:951-7.
2. Schocken DD, Arrieta MJ, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
3. Sharpe DN. Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment. Lancet 1980;2: 1154-7.
4. The Captopril Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988;259:539-44.
5. Kleber FX, Niemoller L, Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich mild heart failure trial. Br Heart J 1992;67:289-96.
6. Cosin J, Rivera M, Solaz J, Hernandez A, Andrés F. Effects of captopril on regional segment motion during acute coronary occlusion. Clin Cardiol 1992;15:411-6.
7. Lindsay DC, Poole-Wilson PA. Angiotensin-converting enzyme inhibitors or vasodilators as therapy in chronic heart failure: a review of the trials. J Cardiovasc Pharmacol 1992;19(suppl):S45-55.
8. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin converting enzyme inhibition. Lancet 1991; 2:872-6.
9. Pfeffer MA and the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after acute myocardial infarction: results of the Survival and Ventricular Enlargement trial (SAVE). N Engl J Med 1992;327: 669-77.
10. Sharpe DN, Coxon RJ. Clinical and haemodynamic effects of low-dose of captopril in severe chronic heart failure. Br J Clin Pharmacol 1982;14:161S-7S.
11. Levine S, Croog SH, Sudilovsky A, Testa MA. Effects of antihypertensive medications on vitality and well-being. J Fam Pract 1987;25:357-63.
12. Purcell H. Conference review: scientific session of the American College of Cardiology. Br J Clin Pract 1996;50:218-21.
13. Packer M, Georghiade M, Youbg JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993;329:1-7.
14. McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971;285:1441-6.
15. Gradman A, Deedwania P, Cody R, et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol 1989;14:564-70.
16. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
17. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
18. Kober L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction: Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 1995;333:1670-6.
19. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
20. Heck I, Luderitz B, Muller HM, Esser H. A comparison of captopril and digoxin in the treatment of patients with mild-to-moderate chronic heart failure. Clin Ther 1995;17:270-9.
21. Bonaducce D, Petretta M, Arrichiello P, et al. Effects of captopril treatment on left ventricular remodeling and function after anterior myocardial infraction: comparison with digitalis. J Am Coll Cardiol 1992;19:858-63.
22. Just H, Drexler H, Taylor SH, Siegrist J, Schulgen G, Schumaacher M. Captopril versus digoxin in patients with coronary artery disease and mild heart failure: a prospective, double-blind, placebo-controlled multicenter study: the CADS Study Group. Hertz 1993; 18:436-13.
23. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The early termination of clinical trial: causes, consequences, and control. Eur Heart J 1994;15: 721-38.
24. Carew BD, Ahn SA, Boichot HD, et al. for the SOLVD investigators. Recruitment strategies in the Studies of Left Ventricular Dysfunction (SOLVD): strategies for screening and enrollment in two concurrent but separate trials. Control Clin Trials 1992;13: 325-38.
25. Dibianco R, Shabetal R, Kostuk W, Moran J, Schlant RC, Wright R. A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;16:677-83.
26. The German and Austrian Xamoterol Study Group. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. Lancet 1988;1:489-93.
27. Packer M, Gheorghiade M, Young JB, et al. for the RADIANCE Study. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyne inhibitors. N Engl J Med 1993;329:1-7.
28. Uretsky FB, Young JB, Shahidi E, Yellen LG, Harrison MC, Jolly KB on behalf of the PROVED Investigative Group. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate congestive heart failure: results of PROVED trial. J Am Coll Cardiol 1993;22:955-62.
29. Gheorghiade M, Ferguson D. Digoxin neurohormonal modulator in heart failure. Circulation 1991;84:2181-6.
30. Yusuf S, Garg R, Held P, Gorlin R. Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure. Am J Cardiol 1992;69:64G-70G.
31. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kemp FJ, Kienzle MG. Sympatho-inhibitory responses to digitalis glycosides in heart failure patients: direct evidences from sympathetic neural recordings. Circulation 1989;80:65-77.
32. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
33. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease: short-term reductions in blood pressure overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-38.